EastPharma Ltd. announced revenue results for the nine months of 2013. For the period, the company's revenue in the nine months of 2013 was USD 164.1 million, down 3.9% from USD 170.8 million for the same period in 2012. The company's sales decrease was mainly driven by decreased volumes in DEVA's Veterinary business.
1st Jan change | Capi. | |
---|---|---|
+19.62% | 43.34B | |
+20.44% | 21.96B | |
+10.86% | 14.09B | |
+13.07% | 13.64B | |
+37.46% | 11.43B | |
-8.59% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.22B |